BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5323240)

  • 21. An anemia-inducing virus derived from tumors caused by murine sarcoma virus--Moloney.
    Taylor DO; Cremer NE; Oshiro LS; Lennette EH
    J Natl Cancer Inst; 1972 Sep; 49(3):829-45. PubMed ID: 4345969
    [No Abstract]   [Full Text] [Related]  

  • 22. Complement fixation and tissue culture assays for mouse leukemia viruses.
    Hartley JW; Rowe WP; Capps WI; Huebner RJ
    Proc Natl Acad Sci U S A; 1965 May; 53(5):931-8. PubMed ID: 4287967
    [No Abstract]   [Full Text] [Related]  

  • 23. ESP-1 helper virus: characterization of type-specific envelope specificities distinct from those of the murine leukemia viruses.
    Eckner RJ; Priori ES; Mirand EA; Dmochowski L
    Bibl Haematol; 1975; (40):607-9. PubMed ID: 51638
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA; Chirigos MA; Chan SP
    Cancer Res; 1969 May; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract]   [Full Text] [Related]  

  • 25. Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30.
    Ikeda H; Pincus T; Yoshiki T; Strand M; August JT; Boyse EA; Mellors RC
    J Virol; 1974 Nov; 14(5):1274-80. PubMed ID: 4139291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of murine retrovirus polypeptide termination: effect of amber suppressor tRNA on the cell-free translation of Rauscher murine leukemia virus, Moloney murine leukemia virus, and Moloney murine sarcoma virus 124 RNA.
    Murphy EC; Wills N; Arlinghaus RB
    J Virol; 1980 May; 34(2):464-73. PubMed ID: 7373716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term in vitro cultivation of Rauscher Leukemia virus in rat embryo cells.
    Rhim JS; Joglekar MH; Richardson ES; Wivel NA; Huebner RJ
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):160-6. PubMed ID: 4319920
    [No Abstract]   [Full Text] [Related]  

  • 28. Replication of defective and competent forms of murine sarcoma virus in mouse cell cultures.
    Fischinger PJ; O'Connor TE
    Virology; 1970 Jun; 41(2):233-43. PubMed ID: 4316311
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.
    Chen W; Qin H; Chesebro B; Cheever MA
    J Virol; 1996 Nov; 70(11):7773-82. PubMed ID: 8892898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mouse strain resistant to N-, B-, and NB-tropic murine leukemia viruses.
    Kai K; Ikeda H; Yuasa Y; Suzuki S; Odaka T
    J Virol; 1976 Nov; 20(2):436-40. PubMed ID: 185426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concentration by Diaflo ultrafiltration of murine leukemia and sarcoma viruses grown in tissue cultures.
    Rhim JS; Williams LB; Huebner RJ; Turner HC
    Cancer Res; 1969 Jan; 29(1):154-6. PubMed ID: 4303443
    [No Abstract]   [Full Text] [Related]  

  • 32. CYTOPATHOGENIC EFFECTS IN A CELL CULTURE INFECTED WITH A MURINE LEUKEMIA VIRUS.
    TYNDALL RL; VIDRINE JG; TEETER E; UPTON AC; HARRIS WW; FINK MA
    Proc Soc Exp Biol Med; 1965 May; 119():186-9. PubMed ID: 14297842
    [No Abstract]   [Full Text] [Related]  

  • 33. Different lymphoid cell targets by transformation by replication-competent Moloney and Rauscher mouse leukemia viruses.
    Reddy EP; Dunn CY; Aaronson SA
    Cell; 1980 Mar; 19(3):663-9. PubMed ID: 6767548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agglutination of murine leukemia viruses by specific immune sera as observed by electron microscopy.
    Mayyasi SA; Schidlovsky G; Bulfone L
    Virology; 1965 Nov; 27(3):431-4. PubMed ID: 5850887
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancement of murine sarcoma virus (Moloney) infection and tumorigenesis in vivo by coinfection with Rauscher leukemia virus.
    Turner W; Chirigos MA
    Cancer Res; 1969 Nov; 29(11):1956-60. PubMed ID: 5358213
    [No Abstract]   [Full Text] [Related]  

  • 36. Production and characterization of human cell-adapted murine Rauscher virus pseudotype of murine sarcoma virus.
    Ablashi DV; Armstrong GR; Turner W
    J Natl Cancer Inst; 1973 Feb; 50(2):381-5. PubMed ID: 4349764
    [No Abstract]   [Full Text] [Related]  

  • 37. Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses.
    Vogt M; Haggblom C; Swift S; Haas M
    J Virol; 1985 Jul; 55(1):184-92. PubMed ID: 4009793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and immunologic characterization of an oncornavirus glycoprotein.
    Kennel SJ; delVillano BC; Levy RL; Lerner RA
    Bibl Haematol; 1975; (40):329-38. PubMed ID: 169812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses.
    Chirigos MA; Perk K; Turner W; Burka B; Gomez M
    Cancer Res; 1968 Jun; 28(6):1055-63. PubMed ID: 5658439
    [No Abstract]   [Full Text] [Related]  

  • 40. Some characteristics of an isolated group antigen common to most strains of murine leukemia virus.
    Fink MA; Sibal LR; Wivel NA; Cowles CA; O'Conner TE
    Virology; 1969 Apr; 37(4):605-14. PubMed ID: 4305633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.